Home > Insider Trading > Filing (0001209191-17-066415)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368148	Athersys Inc / New	ATHX	Pharmaceutical Preparations (2834)	204864095

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402610	J John Harrington	3201 Carnegie Avenue Cleveland OH 44115-2634	Exec Vice Pres And Cso	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2017-12-15	7,500	$1.68	658,474	No	4	S	Direct
Common Stock	Disposition	2017-12-18	8,442	$1.67	650,032	No	4	F	Direct
Common Stock	Disposition	2017-12-18	7,500	$1.77	642,532	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	F	Direct
No	4	S	Direct

Footnotes

Shares sold pursuant to a predefined Rule 10b5-1 trading plan for tax and planning purposes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.665 to $1.69, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted for tax and planning purposes.
Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the minimum tax withholding obligation.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.710 to $1.815, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted for tax and planning purposes.
Securities beneficially owned are comprised of: (1) 392,092 shares of common stock owned and (2) unvested restricted stock units aggregating 250,440 related to annual awards, which vest quarterly over a four-year period from grant date.